Search
for
Sort by
Research 121–150 of 1000+
- Patients with vitiligo present fewer cardiovascular risk factors: results from a case–control study
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Safety of testosterone treatment in postmenopausal women
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case–Control Study
- Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome
- The Safety of Testosterone Therapy in Women
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Testosterone Treatment in Women – An Overview
- Association Between Premature Hair Greying and Metabolic Risk Factors: A Cross-sectional Study
- Nonalcoholic fatty liver disease in young adult Egyptian women with polycystic ovary syndrome
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Occult fungal infection is the underlying pathogenic cause of atherogenesis
- Association of Androgenic Alopecia with Metabolic Syndrome
- Metabolic Syndrome in Patients with Plantar Corns and Calluses: A Case-Control Study
- Women’s Health Considerations for Lipid Management
- Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization
- HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- Cholesterol homeostasis in hair follicle keratinocytes is disrupted by impaired ABCA5 activity
- Avaliação do impacto da redução significativa de peso pela dieta cetogênica de muito baixa caloria nos parâmetros metabólicos, inflamatórios, hormonais e seminais de homens obesos
- Testosterone therapy for transgender men
- Cardiac flow parameters with conventional and pulsed tissue Doppler echocardiography imaging in patients with polycystic ovary syndrome